House Dems Seek Tougher Drug Trial Reporting Rules
A group of House Democrats, including the ranking member of the Energy and Commerce Committee, introduced a bill Thursday that would expand the federal clinical trials database, impose stricter reporting requirements...To view the full article, register now.
Already a subscriber? Click here to view full article